Presenter: Aneesh Singhal, MD, Vice-Chair of Neurology | Quality and Safety, Massachusetts General Hospital; Director, Comprehensive Stroke Center, Massachusetts General Hospital; Associate Professor of Neurology, Harvard Medical School

Learning Objectives:

• Characterize RCVS: clinical and imaging features, diagnosis
• Discuss triggers and risk factors with emphasis on ‘vasoactive’ medications

Presenter: Eric D. Wish, Ph.D., Director, Center for Substance Abuse Research (CESAR) 

Learning Objectives:

• Explain the need for objective measures to identify emerging drugs
• Understand the value of urinalysis as part of a drug early warning system
• Discuss the need for a national system of expanded testing of specimens

Presenter: Mike Twiner, MD, PhD, Detroit Receiving Hospital and Harper University Hospital, Wayne State University

Learning Objectives:

• Review the most commonly encountered algal toxins that pose a threat to human health in North America.
  
• Understand the general toxidromes and geographical predominance of algal toxins that can help rapidly identify a poisoning event.
  
• Understand the basic mechanisms of action of the algal toxins and review the available treatments.

Presenter: Dr. Matthew McGraw, Assistant Professor of Pediatric Pulmonology, University of Rochester  

Learning Objectives:

• Create a differential diagnosis for respiratory failure in an adolescent male
• Discuss causes of direct and indirect toxicity of e-cigarettes
• Identify areas of future research regarding lipid metabolism and pulmonary toxicology

Presenter: Roy Gerona, Ph.D., Assistant Professor, Department of Obstetrics/Gynecology and Reproductive Sciences, University of California, San Francisco 

Learning Objectives:

• Define and differentiate NPS from traditional illicit drugs.
• Identify and discuss currently available laboratory testing to detect and confirm NPS in patient samples.
• Enumerate and discuss the unique requirements of NPS testing.
• Discuss the role of specialty laboratories and surveillance networks in addressing NPS exposure.

Presenter: Amy L. Dzierba, Pharm.D., FCCM, FCCP, BCPS, BCCCP, Clinical Pharmacy Manager, Adult Critical Care, NewYork-Presbyterian Hospital 

Learning Objectives:

• Explain altered pharmacokinetics in critically ill patients receiving extracorporeal membrane oxygenation (ECMO)
• Evaluate recent literature on the management of pain, agitation, and delirium in patients receiving ECMO
• Discuss ways to provide optimal antimicrobial therapy to patients receiving ECMO 

Presenter: Joshua C. Reynolds, MD, MS, Assistant Professor of Emergency Medicine, Michigan State University College of Human Medicine

Learning Objectives:

• Case presentation
• ECMO 101 – terminology, equipment, logistics
• Why consider poisoned patients for ECMO?
• Supporting evidence
• Can my institution do this?

Presenter: Richard Ko, Pharm.D., Ph.D., Principal Food and Drug Consultant, Herbal Synergy

Learning Objectives:

• Have an overview knowledge of selective toxicity related to herbs
• Have an understanding of common herb-drug interactions and its related toxicity
• Learn and acquire tools to investigate herb toxicity

Presenter: Kara Pappas, MD, Clinical and Biochemical Geneticist, Children’s Hospital of Michigan; Assistant Professor of Pediatrics, Wayne State University School of Medicine

Learning Objectives:

• Clues that you are dealing with an inborn error of metabolism
• Recognizing cardinal features of organic acidemias, fatty acid oxidation disorders, and urea cycle disorders
• Diagnosis of inborn errors of metabolism

Presenter: Jason Rose, MD, MBA - Assistant Professor of Medicine, University of Pittsburgh School of Medicine

Learning Objectives:

• Learn about the current management difficulties with the treatment of carbon monoxide poisoning
• Discussion about the concept of molecular carbon monoxide scavenging as a potential mechanism for treating CO poisoning

Presenter: David S. Auerbach, Ph.D., Research Assistant Professor, Department of Medicine, Aab Cardiovascular Research Institute

Learning Objectives:

• Anti-seizure and anti-depressant drugs have ion channel altering properties, which may augment a patient’s risk of arrhythmias.
• It is important to understand the patient’s baseline risk of arrhythmias, and the mechanism(s) of drug action / off-target effects before initiating pharmacological therapies.

Presenter: Brian Grahan, MD, PhD - Addiction Medicine/Internal Medicine/Quality Measurement, Hennepin Healthcare 

Learning Objectives:

• Screen adolescents for substance use disorders with validated tools
• Apply a diagnostic framework to assess for possible substance use disorders
• Provide tailored interventions in clinic and acute settings
• Describe treatment options for adolescent alcohol and opioid use disorders

Moderator:  Timothy J. Wiegand, MD, FACMT -Director of Toxicology and of the Toxicology Consult Service at the University of Rochester Medical Center in Rochester, NY. 

Presenter: Tracey Loveland, CMBS -Certified Medical Billing Specialist & Special Projects Coordinator, Emergency Associates. 

Presenter: Rosalie Wratni, Director of Reimbursement, Emergency Associates

Learning Objectives:

• To describe how to implement effective billing and reimbursement in a Medical Toxicology practice
• To review how the new specialty code will impact billing and reimbursement for Medical Toxicology practice
• To provide an overview of ICD10 with relation to common Medical Toxicology billing opportunities
• To give an overview of the most common billing opportunities in an ED, hospital and clinic setting for a Medical Toxicologist
• To describe how to implement billing in a toxicology clinic including management of patients with addiction for a variety of diagnosis including with buprenorphine (Medication Assisted Treatment)

Learning Objectives:

• The learner will be able to evaluate the relationship between methadone and the QTc interval
• The learner will become aware of current practice guidelines regarding methadone and cardiac safety
• The learner will weigh the clinical relevance of methadone’s role in precipitating events

Learning Objectives:

• Understand the role of drug metabolism in acetaminophen liver injury.
• Review limitations of current diagnostic approaches.
• Understand basic principles of new diagnostics development for acetaminophen liver injury. 

Learning Objectives:

• Outline the principles around informed consent, capacity, and medical necessity that inform the voluntary or involuntary treatment of an acute toxicology patient
• Discuss psychological themes in medical relationships that affect pathways to ethical care
• Introduce concepts from neuroscience that impact how we care for patients and how they choose that care

Learning Objectives:

• Describe the three components of an ECMO circuit
• Understand general indications and contraindications for ECMO support
• Describe use of venoarterial (VA) ECMO to support poisoning-related cardiogenic shock, and issues related to triage and transfer of ECMO candidates with severe poisoning

Learning Objectives:

• Describe the epidemiology of pesticide poisonings in India and Punjab
• Discuss the clinical experience with organophosphate poisonings in Punjab
• Discuss the use of oximes in the organophosphate poisoning

Learning Objectives:

• Review clinical vignettes of acute weakness
• Review clinical presentation of NMJ toxins and how to differentiate the syndromes
• Discuss specific antitoxins and their indications, side effects

Learning Objectives:

• Describe the process for obtaining certification for prescribing buprenorphine for the treatment of opioid dependence.
• Describe the induction process for buprenorphine in the ED and hospital setting for use in opioid-dependent patients admitted with serious infections related to injection drug use.
• Describe the use of adjunctive medications (e.g. clonidine, hydroxyzine) during the transition from full opioid agonists onto buprenorphine products.
• Describe billing and reimbursement opportunities related to use of buprenorphine in the hospital and clinic setting.

Learning Objectives:

• Appreciate the opportunities and challenges inherent in advanced toxicologic testing for different novel synthetic psychoactive compounds
• Gather sufficient knowledge about the current state of available testing for synthetic psychoactives to make carefully measured applications to clinical practice

Learning Objectives:

• Review the basics of ammonia production and metabolism;
• Highlight the clinical features of hyperammonemia;
• Present a practical diagnostic algorithm for patients who present with acute ammonia elevations;
• Discuss current and future therapies aimed at both acute and chronic management of hyperammonemia

Learning Objectives:

• To understand safety culture’s influence on key radiation protection principles
• To discuss the current evidence and uncertainty around risk from ionizing radiation in medicine.
• To understand both qualitative and quantitative tools in appropriate use of medical imaging

Mr. Chris Duggar, Chief of Country Strategy and Implementation Branch, Division of Health Protection, CDC Center for Global Health

Dr. Vikas Kapil, Chief Medical Officer, CDC Center for Global Health

Dr. Ziad Kazzi, FACMT, Co-Chair, ACMT International Committee

Dr. Rais Vohra, FACMT, Co-Chair, ACMT International Committee 

Learning Objectives:

• Describe the roles of CDC in Global Health
• Describe the Global Health Security Initiative
• Discuss the potential roles of medical toxicologists in Global Health

Learning Objective:

Evidence-based medical practice is the current standard of clinical practice. We believe that we now know why individuals are dying during the current overdose epidemic, but that is a matter of understanding the rapidly changing field of Forensic Toxicology and in interpreting an extremely complex laboratory document – the toxicology report. The presentation will discuss some of these complexities in the context of the current crisis as seen in the Commonwealth of Pennsylvania.

Research on academic writing has found that small changes in work habits can lead to large gains in productivity, as well as make writing more enjoyable. In this webinar, the audience will learn:

• Understand the opioid overdose and chronic pain epidemics
• Learn about risk management in opioid prescribing
• Learn more about opioid addiction and pain management in opioid addicted patients

Dr. Anne M Pylkas, MD is board certified in internal medicine and addiction medicine. She attended medical school at the University of Minnesota and completed her residency and addiction medicine training at Hennepin County Medical Center (HCMC) in Minneapolis. She is an Assistant Professor at the University of Minnesota, teaching medical students and residents. At HCMC, she treated opioid dependence in a methadone clinic setting and was a primary care provider for a medically and socially complex population. She also helped develop a curriculum for Chronic Opioid Treatment for Chronic Pain in Primary Care and Screening and Brief Intervention for primary care physicians. She now also works at HealthPartners Interventional Pain Clinic in St. Paul, treating complex chronic pain and addiction.  She is the Medical Director of Sage Prairie Recovery, an outpatient chemical dependency treatment program in Burnsville, MN.